{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:40:18Z","timestamp":1760708418037},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00393-011-0858-7","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T13:58:32Z","timestamp":1334671112000},"page":"187-198","source":"Crossref","is-referenced-by-count":1,"title":["Immunrekonstitutionssyndrome"],"prefix":"10.1007","volume":"71","author":[{"given":"D.","family":"Meyer-Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,15]]},"reference":[{"key":"858_CR1","first-page":"17","volume":"1","author":"Casadevall","year":"2003","unstructured":"Casadevall A, Pirofski LA (2003) The damage-response framework of microbial pathogenesis. Nature reviews. Microbiology 1:17\u201324","journal-title":"Microbiology"},{"key":"858_CR2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pt.2011.05.004","volume":"27","author":"Sears","year":"2011","unstructured":"Sears BF, Rohr JR, Allen JE, Martin LB (2011) The economy of inflammation: When is less more? Trends Parasitol 27:382\u2013387","journal-title":"Trends Parasitol"},{"key":"858_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1098\/rstb.2008.0157","volume":"364","author":"Schmid-Hempel","year":"2009","unstructured":"Schmid-Hempel P (2009) Immune defence, parasite evasion strategies and their relevance for \u201emacroscopic phenomena\u201c such as virulence. Philos Trans R Soc Lond B Biol Sci 364:85\u201398","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"858_CR4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1055\/s-2001-17113","volume":"126","author":"Stoll","year":"2001","unstructured":"Stoll M, Behrens GM, Schmidt RE (2001) Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs. Dtsch Med Wochenschr 126:1017\u20131022","journal-title":"Dtsch Med Wochenschr"},{"key":"858_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11908-003-0083-x","volume":"5","author":"Stoll","year":"2003","unstructured":"Stoll M, Schmidt RE (2003) Immune restoration inflammatory syndromes: the dark side of successful antiretroviral treatment. Curr Infect Dis Rep 5:266\u2013276","journal-title":"Curr Infect Dis Rep"},{"key":"858_CR6","unstructured":"Stoll M, Heiken H, Behrens GM, Schmidt RE (2004) Immune restoration inflammatory syndromes. Internist (Berl) 45:893\u2013903"},{"key":"858_CR7","first-page":"67","volume":"5","author":"Shelburne","year":"2003","unstructured":"Shelburne SA iii, Hamill RJ (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5:67\u201379","journal-title":"AIDS Rev"},{"key":"858_CR8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","volume":"18","author":"French","year":"2004","unstructured":"French MA, Price P, Stone SF (2004) Immune restoration disease after antiretroviral therapy. Aids 18:1615\u20131627","journal-title":"Aids"},{"key":"858_CR9","doi-asserted-by":"crossref","unstructured":"French MA (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV\/AIDS Rep 4:16\u201321","DOI":"10.1007\/s11904-007-0003-z"},{"key":"858_CR10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/3.3.422","volume":"3","author":"Sansonetti","year":"1981","unstructured":"Sansonetti P, Lagrange PH (1981) The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis 3:422\u2013469","journal-title":"Rev Infect Dis"},{"key":"858_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(84)90478-1","volume":"2","author":"Chambers","year":"1984","unstructured":"Chambers ST, Hendrickse WA, Record C et al (1984) Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 2:181\u2013184","journal-title":"Lancet"},{"key":"858_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0041-3879(77)90041-1","volume":"58","author":"Campbell","year":"1977","unstructured":"Campbell IA, Dyson AJ (1977) Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 58:171\u2013179","journal-title":"Tubercle"},{"key":"858_CR13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QCO.0b013e32832d7aff","volume":"22","author":"Sun","year":"2009","unstructured":"Sun HY, Singh N (2009) Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr Opin Infect Dis 22:394\u2013402","journal-title":"Curr Opin Infect Dis"},{"key":"858_CR14","first-page":"85","volume":"25","author":"Bjune","year":"1976","unstructured":"Bjune G, Barnetson RS, Ridley DS, Kronvall G (1976) Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions. Clin Exp Immunol 25:85\u201394","journal-title":"Clin Exp Immunol"},{"key":"858_CR15","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1086\/528864","volume":"46","author":"Batista","year":"2008","unstructured":"Batista MD et al (2008) Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clin Infect Dis 46:e56\u201360","journal-title":"Clin Infect Dis"},{"key":"858_CR16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10096-002-0821-2","volume":"21","author":"Cheng","year":"2002","unstructured":"Cheng VC et al (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803\u2013809","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"858_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0954-6111(96)90289-9","volume":"90","author":"Al-Majed","year":"1996","unstructured":"Al-Majed SA (1996) Study of paradoxical response to chemotherapy in tuberculous pleural effusion. Respir Med 90:211\u2013214","journal-title":"Respir Med"},{"key":"858_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","volume":"110","author":"Miceli","year":"2007","unstructured":"Miceli MH et al (2007) Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 110:112\u2013120","journal-title":"Cancer"},{"key":"858_CR19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","volume":"46","author":"Legrand","year":"2008","unstructured":"Legrand F et al (2008) Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 46:696\u2013702","journal-title":"Clin Infect Dis"},{"key":"858_CR20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/522182","volume":"45","author":"Singh","year":"2007","unstructured":"Singh N, Perfect JR (2007) Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45:1192\u20131199","journal-title":"Clin Infect Dis"},{"key":"858_CR21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","volume":"40","author":"Singh","year":"2005","unstructured":"Singh N et al (2005) An immune reconstitution syndrome-like illness associated with cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 40:1756\u20131761","journal-title":"Clin Infect Dis"},{"key":"858_CR22","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","volume":"80","author":"Singh","year":"2005","unstructured":"Singh N et al (2005) Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 80:1131\u20131133","journal-title":"Transplantation"},{"key":"858_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3062.2006.00194.x","volume":"9","author":"Place","year":"2007","unstructured":"Place S et al (2007) Paradoxical worsening of tuberculosis in a heart-lung transplant recipient. Transpl Infect Dis 9:219\u2013224","journal-title":"Transpl Infect Dis"},{"key":"858_CR24","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0041-1345(00)01512-8","volume":"32","author":"Asano","year":"2000","unstructured":"Asano T et al (2000) Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient. Transplant Proc 32:1960\u20131962","journal-title":"Transplant Proc"},{"key":"858_CR25","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/lt.21601","volume":"14","author":"Crespo","year":"2008","unstructured":"Crespo G et al (2008) Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient. Liver Transpl 14:1671\u20131674","journal-title":"Liver Transpl"},{"key":"858_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1399-3062.2007.00285.x","volume":"10","author":"Egli","year":"2008","unstructured":"Egli A et al (2008) Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transpl Infect Dis 10:27\u201343","journal-title":"Transpl Infect Dis"},{"key":"858_CR27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e3181814e76","volume":"86","author":"Singh","year":"2008","unstructured":"Singh N et al (2008) Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation 86:647\u2013651","journal-title":"Transplantation"},{"key":"858_CR28","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","volume":"7","author":"Lanternier","year":"2007","unstructured":"Lanternier F et al (2007) Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant 7:2826\u20132828","journal-title":"Am J Transplant"},{"key":"858_CR29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","volume":"40","author":"Garcia","year":"2005","unstructured":"Garcia Vidal C et al (2005) Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40:756\u2013759","journal-title":"Clin Infect Dis"},{"key":"858_CR30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","volume":"45","author":"Arend","year":"2007","unstructured":"Arend SM, Leyten EM, Franken WP et al (2007) A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 45:1470\u20131475","journal-title":"Clin Infect Dis"},{"key":"858_CR31","first-page":"1057","volume":"9","author":"Belknap","year":"2005","unstructured":"Belknap R, Reves R, Burman W (2005) Immune reconstitution to mycobacterium tuberculosis after discontinuing infliximab. Int J Tuberc Lung Dis 9:1057\u20131058","journal-title":"Int J Tuberc Lung Dis"},{"key":"858_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WCO.0b013e328346be57","volume":"24","author":"Johnson","year":"2011","unstructured":"Johnson T, Nath A (2011) Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 24:284\u2013290","journal-title":"Curr Opin Neurol"},{"key":"858_CR33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1212\/WNL.0b013e3181f07362","volume":"75","author":"Lenhard","year":"2010","unstructured":"Lenhard T et al (2010) Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 75:831\u2013833","journal-title":"Neurology"},{"key":"858_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"Clifford","year":"2010","unstructured":"Clifford DB et al (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438\u2013446","journal-title":"Lancet Neurol"},{"key":"858_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneurol.2010.257","volume":"68","author":"Miravalle","year":"2011","unstructured":"Miravalle A, Jensen R, Kinkel RP (2011) Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol 68:186\u2013191","journal-title":"Arch Neurol"},{"key":"858_CR36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s100960100507","volume":"20","author":"Cheng","year":"2001","unstructured":"Cheng VC et al (2001) Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20:402\u2013406","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"858_CR37","doi-asserted-by":"crossref","unstructured":"Shelburne SA 3rd et al (2002) Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81:213\u2013227","DOI":"10.1097\/00005792-200205000-00005"},{"key":"858_CR38","unstructured":"French MA, Meintjes G (2010) In: Cohen J, Opal SM, Powderly WG (Hrsg) Infectious diseases, Vol. 2, Ch. 92. MOSBY Elsevier"},{"key":"858_CR39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1586\/eri.11.21","volume":"9","author":"Lawn","year":"2011","unstructured":"Lawn SD, Meintjes G (2011) Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther 9:415\u2013430","journal-title":"Expert Rev Anti Infect Ther"},{"key":"858_CR40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diagmicrobio.2009.03.019","volume":"64","author":"Cadena","year":"2009","unstructured":"Cadena J et al (2009) Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. Diagn Microbiol Infect Dis 64:327\u2013330","journal-title":"Diagn Microbiol Infect Dis"},{"key":"858_CR41","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.ijid.2010.03.002","volume":"14","author":"Melboucy-Belkhir","year":"2010","unstructured":"Melboucy-Belkhir S et al (2010) Prolonged paradoxical response to anti-tuberculous treatment after infliximab. Int J Infect Dis 14(Suppl 3):e333\u2013334","journal-title":"Int J Infect Dis"},{"key":"858_CR42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11096-010-9369-x","volume":"32","author":"Troncoso","year":"2010","unstructured":"Troncoso Marino A, Campelo Sanchez E, Martinez Lopez de Castro N, Inaraja Bobo MT (2010) Haemophagocytic syndrome and paradoxical reaction to tuberculostatics after treatment with infliximab. Pharm World Sci 32:117\u2013119","journal-title":"Pharm World Sci"},{"key":"858_CR43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-4-57","volume":"4","author":"Wu","year":"2004","unstructured":"Wu AK et al (2004) The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review. BMC Infect Dis 4:57","journal-title":"BMC Infect Dis"},{"key":"858_CR44","first-page":"210","volume":"11","author":"Hung","year":"2005","unstructured":"Hung IF, Cheng VC, Lo WK, Lui SL (2005) Paradoxical deterioration during anti-tubercular treatment in a dialysis patient on maintenance steroid therapy. Hong Kong Med J 11:210\u2013212","journal-title":"Hong Kong Med J"},{"key":"858_CR45","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1186\/1752-1947-3-6673","volume":"3","author":"Yoon","year":"2009","unstructured":"Yoon YK et al (2009) Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report. J Med Case Reports 3:6673","journal-title":"J Med Case Reports"},{"key":"858_CR46","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-153-11-201012070-00004","volume":"153","author":"Feurle","year":"2010","unstructured":"Feurle GE et al (2010) The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med 153:710\u2013717","journal-title":"Ann Intern Med"},{"key":"858_CR47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-011-0900-5","volume":"123","author":"Metz","year":"2011","unstructured":"Metz I et al (2011) Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123(2):235\u2013254","journal-title":"Acta Neuropathol"},{"key":"858_CR48","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.ijid.2010.09.006","volume":"15","author":"Narayanan","year":"2011","unstructured":"Narayanan S, Banerjee C, Holt PA (2011) Cryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine. Int J Infect Dis 15:e70\u201373","journal-title":"Int J Infect Dis"},{"key":"858_CR49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.tp.0000185461.21901.5b","volume":"81","author":"Hung","year":"2006","unstructured":"Hung YM (2006) Pneumocystis carinii pneumonia with hypercalcemia and suppressed parathyroid hormone levels in a renal transplant patient. Transplantation 81:639","journal-title":"Transplantation"},{"key":"858_CR50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-3062.2010.00592.x","volume":"13","author":"Legris","year":"2011","unstructured":"Legris T et al (2011) Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient. Transpl Infect Dis 13:303\u2013308","journal-title":"Transpl Infect Dis"},{"key":"858_CR51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","volume":"53","author":"Sun","year":"2011","unstructured":"Sun HY, Singh N (2011) Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin Infect Dis 53:168\u2013176","journal-title":"Clin Infect Dis"},{"key":"858_CR52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/clinids\/24.3.375","volume":"24","author":"Anttila","year":"1997","unstructured":"Anttila VJ et al (1997) Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 24:375\u2013380","journal-title":"Clin Infect Dis"},{"key":"858_CR53","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/MPH.0b013e3181b795ec","volume":"31","author":"Saint-Faust","year":"2009","unstructured":"Saint-Faust M et al (2009) Adjuvant corticosteroid therapy in 2 children with hepatosplenic candidiasis-related IRIS. J Pediatr Hematol Oncol 31:794\u2013796","journal-title":"J Pediatr Hematol Oncol"},{"key":"858_CR54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2362.1999.00474.x","volume":"29","author":"Todeschini","year":"1999","unstructured":"Todeschini G et al (1999) Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 29:453\u2013457","journal-title":"Eur J Clin Invest"},{"key":"858_CR55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2796.2002.01012.x","volume":"252","author":"Takuma","year":"2002","unstructured":"Takuma T, Okada K, Uchida Y et al (2002) Invasive pulmonary aspergillosis resulting in respiratory failure during neutrophil recovery from postchemotherapy neutropenia in three patients with acute leukaemia. J Intern Med 252:173\u2013177","journal-title":"J Intern Med"},{"key":"858_CR56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1705305","volume":"37","author":"Sreedharan","year":"2006","unstructured":"Sreedharan A et al (2006) Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant 37:629\u2013634","journal-title":"Bone Marrow Transplant"},{"key":"858_CR57","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/bmt.2010.267","volume":"46","author":"Lapusan","year":"2011","unstructured":"Lapusan S et al (2011) Immune reconstitution inflammatory syndrome following allo-SCT in a patient with Dipodascus capitatus spondylodiscitis. Bone Marrow Transplant 46:1265\u20131267","journal-title":"Bone Marrow Transplant"},{"key":"858_CR58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2001-17861","volume":"18","author":"Gaunt","year":"2001","unstructured":"Gaunt G, Ramin K (2001) Immunological tolerance of the human fetus. Am J Perinatol 18:299\u2013312","journal-title":"Am J Perinatol"},{"key":"858_CR59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/CRIAI:26:3:161","volume":"26","author":"Poole","year":"2004","unstructured":"Poole J, Claman HN (2004) Immunology of pregnancy. Implications for the mother. Clin Rev Allergy Immunol 26:161\u2013170","journal-title":"Clin Rev Allergy Immunol"},{"key":"858_CR60","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11926-011-0199-1","volume":"13","author":"Amin","year":"2011","unstructured":"Amin S, Peterson EJ, Reed AM, Mueller DL (2011) Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity. Curr Rheumatol Rep 13:449\u2013455","journal-title":"Curr Rheumatol Rep"},{"key":"858_CR61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10096-003-0998-z","volume":"22","author":"Cheng","year":"2003","unstructured":"Cheng VC et al (2003) Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 22:313\u2013317","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"858_CR62","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1086\/424746","volume":"39","author":"Einsiedel","year":"2004","unstructured":"Einsiedel L, Gordon DL, Dyer JR (2004) Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis 39:e78\u201382","journal-title":"Clin Infect Dis"},{"key":"858_CR63","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00393-010-0677-2","volume":"69","author":"Meyer-Olson","year":"2010","unstructured":"Meyer-Olson D, Hoeper K, Schmidt RE (2010) Infectious complications of biologic therapy in patients with rheumatoid arthritis. Z Rheumatol 69:879\u2013888","journal-title":"Z Rheumatol"},{"key":"858_CR64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/648724","volume":"50","author":"Hage","year":"2010","unstructured":"Hage CA et al (2010) Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 50:85\u201392","journal-title":"Clin Infect Dis"},{"key":"858_CR65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1527-3458.2007.00003.x","volume":"13","author":"Stuve","year":"2007","unstructured":"Stuve O, Bennett JL (2007) Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases. CNS Drug Rev 13:79\u201395","journal-title":"CNS Drug Rev"},{"key":"858_CR66","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"Yousry","year":"2006","unstructured":"Yousry TA et al (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924\u2013933","journal-title":"N Engl J Med"},{"key":"858_CR67","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","volume":"361","author":"Wenning","year":"2009","unstructured":"Wenning W et al (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075\u20131080","journal-title":"N Engl J Med"},{"key":"858_CR68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","volume":"72","author":"Khatri","year":"2009","unstructured":"Khatri BO et al (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402\u2013409","journal-title":"Neurology"},{"key":"858_CR69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05789.x","volume":"132","author":"Thursky","year":"2006","unstructured":"Thursky KA, Worth LJ, Seymour JF et al (2006) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*. Br J Haematol 132:3\u201312","journal-title":"Br J Haematol"},{"key":"858_CR70","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1086\/518168","volume":"44","author":"Ingram","year":"2007","unstructured":"Ingram PR, Howman R, Leahy MF, Dyer JR (2007) Cryptococcal immune reconstitution inflammatory syndrome following alemtuzumab therapy. Clin Infect Dis 44:e115\u2013117","journal-title":"Clin Infect Dis"},{"key":"858_CR71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000441-200702000-00014","volume":"333","author":"Otahbachi","year":"2007","unstructured":"Otahbachi M, Nugent K, Buscemi D (2007) Granulomatous pneumocystis jiroveci pneumonia in a patient with chronic lymphocytic leukemia: a literature review and hypothesis on pathogenesis. Am J Med Sci 333:131\u2013135","journal-title":"Am J Med Sci"},{"key":"858_CR72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9343(93)90187-T","volume":"94","author":"Slivka","year":"1993","unstructured":"Slivka A, Wen PY, Shea WM, Loeffler JS (1993) Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 94:216\u2013219","journal-title":"Am J Med"},{"key":"858_CR73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/374048","volume":"36","author":"Berenguer","year":"2003","unstructured":"Berenguer J et al (2003) Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 36:1047\u20131052","journal-title":"Clin Infect Dis"},{"key":"858_CR74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","volume":"38","author":"Foulon","year":"2004","unstructured":"Foulon G et al (2004) Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38:418\u2013425","journal-title":"Clin Infect Dis"},{"key":"858_CR75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.aids.0000196173.42680.5f","volume":"20","author":"Crum","year":"2006","unstructured":"Crum NF, Ganesan A, Johns ST, Wallace MR (2006) Graves disease: an increasingly recognized immune reconstitution syndrome. Aids 20:466\u2013469","journal-title":"Aids"},{"key":"858_CR76","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/424749","volume":"39","author":"Wong","year":"2004","unstructured":"Wong KH, Chow WS, Lee SS (2004) Clinical hyperthyroidism in Chinese patients with stable HIV disease. Clin Infect Dis 39:1257\u20131259","journal-title":"Clin Infect Dis"},{"key":"858_CR77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1258\/095646203321605585","volume":"14","author":"Calza","year":"2003","unstructured":"Calza L et al (2003) Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy. Int J STD AIDS 14:356\u2013359","journal-title":"Int J STD AIDS"},{"key":"858_CR78","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semarthrit.2005.03.007","volume":"35","author":"Calabrese","year":"2005","unstructured":"Calabrese LH, Kirchner E, Shrestha R (2005) Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35:166\u2013174","journal-title":"Semin Arthritis Rheum"},{"key":"858_CR79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2217\/hiv.10.30","volume":"4","author":"Meyer-Olson","year":"2010","unstructured":"Meyer-Olson D, Schmidt RE, Bollmann BA (2010) Treatment and prevention of cytomegalovirus-associated diseases in HIV-1 infection in the era of HAART. HIV Therapy 4:413\u2013436","journal-title":"HIV Therapy"},{"key":"858_CR80","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/jac\/dkh396","volume":"54","author":"Springer","year":"2004","unstructured":"Springer KL, Weinberg A (2004) Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. J Antimicrob Chemother 54:582\u2013586","journal-title":"J Antimicrob Chemother"},{"key":"858_CR81","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S1529-1839(04)70209-2","volume":"75","author":"Roels","year":"2004","unstructured":"Roels P (2004) Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART). Optometry 75:624\u2013628","journal-title":"Optometry"},{"key":"858_CR82","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jama.283.5.653","volume":"283","author":"Whitcup","year":"2000","unstructured":"Whitcup SM (2000) Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 283:653\u2013657","journal-title":"JAMA"},{"key":"858_CR83","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00002030-200006160-00013","volume":"14","author":"Deayton","year":"2000","unstructured":"Deayton JR et al (2000) Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. Aids 14:1163\u20131170","journal-title":"Aids"},{"key":"858_CR84","first-page":"313","volume":"48","author":"Biswas","year":"2000","unstructured":"Biswas J, Choudhry S, Kumarasamy, Solomon S (2000) Immune recovery vitritis presenting as panuveitis following therapy with protease inhibitors. Indian J Ophthalmol 48:313\u2013315","journal-title":"Indian J Ophthalmol"},{"key":"858_CR85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/sti.75.1.18","volume":"75","author":"Rauz","year":"1999","unstructured":"Rauz S, Murray PI (1999) Changing patterns of HIV related ocular disease. Sex Transm Infect 75:18\u201320","journal-title":"Sex Transm Infect"},{"key":"858_CR86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1076\/ocii.7.3.231.4008","volume":"7","author":"Cassoux","year":"1999","unstructured":"Cassoux N, Bodaghi B, Katlama C, LeHoang P (1999) CMV retinitis in the era of HAART. Ocul Immunol Inflamm 7:231\u2013235","journal-title":"Ocul Immunol Inflamm"},{"key":"858_CR87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10096-003-0998-z","volume":"22","author":"Cheng","year":"2003","unstructured":"Cheng VC et al (2003) Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 22:597\u2013602","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"858_CR88","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","volume":"22","author":"Murdoch","year":"2008","unstructured":"Murdoch DM, Venter WD, Feldman C, Van Rie A (2008) Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22:601\u2013610","journal-title":"AIDS"},{"key":"858_CR89","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","volume":"8","author":"Meintjes","year":"2008","unstructured":"Meintjes G et al (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8:516\u2013523","journal-title":"Lancet Infect Dis"},{"key":"858_CR90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","volume":"5","author":"Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Miller RF (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5:361\u2013373","journal-title":"Lancet Infect Dis"},{"key":"858_CR91","doi-asserted-by":"crossref","unstructured":"Muller M et al (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10, 251\u2013261","DOI":"10.1016\/S1473-3099(10)70026-8"},{"key":"858_CR92","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","volume":"179","author":"Karavellas","year":"1999","unstructured":"Karavellas MP et al (1999) Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 179:697\u2013700","journal-title":"J Infect Dis"},{"key":"858_CR93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","volume":"9","author":"Tan","year":"2010","unstructured":"Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9:425\u2013437","journal-title":"Lancet Neurol"},{"key":"858_CR94","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/COH.0b013e328302ebd1","volume":"3","author":"Torok","year":"2008","unstructured":"Torok ME, Kambugu A, Wright E (2008) Immune reconstitution disease of the central nervous system. Curr Opin HIV AIDS 3:438\u2013445","journal-title":"Curr Opin HIV AIDS"},{"key":"858_CR95","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","volume":"80","author":"Singh","year":"2005","unstructured":"Singh N et al (2005) Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation 80:1033\u20131039","journal-title":"Transplantation"},{"key":"858_CR96","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/497269","volume":"41","author":"Phillips","year":"2005","unstructured":"Phillips P et al (2005) Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 41:1483\u20131497","journal-title":"Clin Infect Dis"},{"key":"858_CR97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","volume":"21","author":"Lawn","year":"2007","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R (2007) Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21:335\u2013341","journal-title":"AIDS"},{"key":"858_CR98","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/01.aids.0000202648.18526.bf","volume":"20","author":"Bourgarit","year":"2006","unstructured":"Bourgarit A et al (2006) Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20:F1\u20137","journal-title":"AIDS"},{"key":"858_CR99","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/644784","volume":"200","author":"Elliott","year":"2009","unstructured":"Elliott JH et al (2009) Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 200:1736\u20131745","journal-title":"J Infect Dis"},{"key":"858_CR100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-1293.2000.00012.x","volume":"1","author":"French","year":"2000","unstructured":"French MA et al (2000) Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 1:107\u2013115","journal-title":"HIV Med"},{"key":"858_CR101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","volume":"46","author":"Manabe","year":"2007","unstructured":"Manabe YC, Campbell JD, Sydnor E, Moore RD (2007) Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 46:456\u2013462","journal-title":"J Acquir Immune Defic Syndr"},{"key":"858_CR102","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","volume":"203","author":"Boulware","year":"2011","unstructured":"Boulware DR et al (2011) Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 203:1637\u20131646","journal-title":"J Infect Dis"},{"key":"858_CR103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2010.02.010","volume":"136","author":"Porter","year":"2010","unstructured":"Porter BO et al (2010) d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin Immunol 136:42\u201350","journal-title":"Clin Immunol"},{"key":"858_CR104","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/COH.0b013e32833ed774","volume":"5","author":"Sereti","year":"2010","unstructured":"Sereti I, Rodger AJ, French MA (2010) Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis. Curr Opin HIV AIDS 5:504\u2013510","journal-title":"Curr Opin HIV AIDS"},{"key":"858_CR105","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/CMR.00015-09","volume":"22","author":"Price","year":"2009","unstructured":"Price P et al (2009) Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev 22:651\u2013663","journal-title":"Clin Microbiol Rev"},{"key":"858_CR106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","volume":"277","author":"Autran","year":"1997","unstructured":"Autran B et al (1997) Positive effects of combined antiretroviral therapy on CD4\u2009+\u2009T cell homeostasis and function in advanced HIV disease. Science 277:112\u2013116","journal-title":"Science"},{"key":"858_CR107","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/00002030-199816000-00006","volume":"12","author":"Bisset","year":"1998","unstructured":"Bisset LR et al (1998) Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. AIDS 12:2115\u20132123","journal-title":"AIDS"},{"key":"858_CR108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002030-199902040-00008","volume":"13","author":"Pakker","year":"1999","unstructured":"Pakker NG et al (1999) Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS 13:203\u2013212","journal-title":"AIDS"},{"key":"858_CR109","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.280.1.72","volume":"280","author":"Powderly","year":"1998","unstructured":"Powderly WG, Landay A, Lederman MM (1998) Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 280:72\u201377","journal-title":"JAMA"},{"key":"858_CR110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/595006","volume":"48","author":"French","year":"2009","unstructured":"French MA (2009) HIV\/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 48:101\u2013107","journal-title":"Clin Infect Dis"},{"key":"858_CR111","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/COH.0b013e328302ebbb","volume":"3","author":"Kestens","year":"2008","unstructured":"Kestens L, Seddiki N, Bohjanen PR (2008) Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr Opin HIV AIDS 3:419\u2013424","journal-title":"Curr Opin HIV AIDS"},{"key":"858_CR112","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.120.1.193","volume":"120","author":"Wendel","year":"2001","unstructured":"Wendel KA et al (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193\u2013197","journal-title":"Chest"},{"key":"858_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200102000-00001","volume":"21","author":"Karavellas","year":"2001","unstructured":"Karavellas MP et al (2001) Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina 21:1\u20139","journal-title":"Retina"},{"key":"858_CR114","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","volume":"59","author":"Breen","year":"2004","unstructured":"Breen RA et al (2004) Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 59:704\u2013707","journal-title":"Thorax"},{"key":"858_CR115","first-page":"1282","volume":"11","author":"Burman","year":"2007","unstructured":"Burman W et al (2007) Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis 11:1282\u20131289","journal-title":"Int J Tuberc Lung Dis"},{"key":"858_CR116","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.162.1.97","volume":"162","author":"Navas","year":"2002","unstructured":"Navas E et al (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 162:97\u201399","journal-title":"Arch Intern Med"},{"key":"858_CR117","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","volume":"365","author":"Abdool","year":"2011","unstructured":"Abdool Karim SS et al (2011) Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 365:1492\u20131501","journal-title":"N Engl J Med"},{"key":"858_CR118","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"Blanc","year":"2011","unstructured":"Blanc FX et al (2011) Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 365:1471\u20131481","journal-title":"N Engl J Med"},{"key":"858_CR119","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"Havlir","year":"2011","unstructured":"Havlir DV et al (2011) Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 365:1482\u20131491","journal-title":"N Engl J Med"},{"key":"858_CR120","first-page":"327","volume":"67","author":"Beishuizen","year":"2009","unstructured":"Beishuizen SJ, Geerlings SE (2009) Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention. Neth J Med 67:327\u2013331","journal-title":"Neth J Med"},{"key":"858_CR121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.autrev.2003.09.005","volume":"3","author":"Stoll","year":"2004","unstructured":"Stoll M, Schmidt RE (2004) Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes. Autoimmun Rev 3:243\u2013249","journal-title":"Autoimmun Rev"},{"key":"858_CR122","doi-asserted-by":"crossref","unstructured":"Stoll M, Schmidt RE (2004) Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV\/AIDS Rep 1:122\u2013127","DOI":"10.1007\/s11904-004-0018-7"},{"key":"858_CR123","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","volume":"24","author":"Meintjes","year":"2010","unstructured":"Meintjes G et al (2010) Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 24:2381\u20132390","journal-title":"AIDS"},{"key":"858_CR124","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/605501","volume":"49","author":"Davies","year":"2009","unstructured":"Davies MA, Meintjes G (2009) Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis 49:973\u2013975","journal-title":"Clin Infect Dis"},{"key":"858_CR125","first-page":"1","volume":"53L","author":"Benson","year":"2004","unstructured":"Benson CA, Kaplan JE, Masur H et al (2004) Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association\/Infectious Diseases Society of America. MMWR Recomm Rep 53L:1\u2013112","journal-title":"MMWR Recomm Rep"},{"key":"858_CR126","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"Blumberg","year":"2003","unstructured":"Blumberg HM et al (2003) American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167:603\u2013662","journal-title":"Am J Respir Crit Care Med"},{"key":"858_CR127","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-4-9","volume":"4","author":"Murdoch","year":"2007","unstructured":"Murdoch DM, Venter WD, Van Rie A, Feldman C (2007) Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4:9","journal-title":"AIDS Res Ther"},{"key":"858_CR128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002030-200401230-00015","volume":"18","author":"Wallis","year":"2004","unstructured":"Wallis RS et al (2004) A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS 18:257\u2013264","journal-title":"AIDS"},{"key":"858_CR129","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","volume":"47","author":"Blackmore","year":"2008","unstructured":"Blackmore TK, Manning L, Taylor WJ, Wallis RS (2008) Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 47:e83\u201385","journal-title":"Clin Infect Dis"},{"key":"858_CR130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.mehy.2010.09.019","volume":"76","author":"Sun","year":"2011","unstructured":"Sun HY, Singh N (2011) Potential role of statins for the management of immune reconstitution syndrome. Med Hypotheses 76:307\u2013310","journal-title":"Med Hypotheses"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-011-0858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-011-0858-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T02:26:37Z","timestamp":1642040797000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-011-0858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["858"],"URL":"https:\/\/doi.org\/10.1007\/s00393-011-0858-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}